LiDCO (AIM: LID), the hemodynamic monitoring company, announces that the Board has yesterday, 15 April 2019, finalised the grant of options ('Options') to Mr Sassone, CEO and Mr Hall, CFO, to subscribe for new ordinary shares of 0.5p.
Option type
Number of shares over which options granted
Total number of options held post grant
Percentage of issued share capital under option
Mr Sassone
EMI
Unapproved
-
2,000,000
3,448,262
6,147,342
1.41%
2.52%
Total
2,000,000
9,595,604
3.93%
Mr Hall
EMI
2,000,000
2,000,000
0.82%
A proportion of the Options may vest and be exercised at 0.5 pence per Ordinary Share anytime between 9 April 2022 and 9 April 2025 if the average share price in the three months ending 9 April 2022 (the 'Average Share Price') equals or exceeds 6.00p. At an Average Share Price of 6.00p, 15% of the Options become exercisable, for all of the Options to vest the Average Share Price must equal or exceed 10.00p, and a straight line sliding scale applies to determine the amount vesting if the Average Share Price is between 6.00p and 10.00p.
The Company is currently in the process of finalising share option grants to key employees over a further 1,025,000 Ordinary shares. Following these grants, the total number of shares under option will be 20,478,376 representing 8.4% of the issued share capital.
The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name:
Matt Sassone
2.
Reason for the notification
a)
Position/status:
Chief Executive Officer
b)
Initial notification/Amendment:
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name:
LiDCO Group Plc
b)
LEI:
213800PYQTIUV6HIYL36
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument:
Identification code:
Ordinary Shares of 0.5 pence each
GB0030546849
b)
Nature of the transaction:
Grant of Management Share Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
0.50 pence per share
2,000,000
d)
Aggregated information:
· Aggregated volume:
· Price:
Single transaction as in 4 c) above
Price(s)
Volume(s)
0.50 pence per share
2,000,000
e)
Date of the transaction:
15-04-2019
f)
Place of the transaction:
London Stock Exchange, AIM (XLON)
1.
Details of the person discharging managerial responsibilities/person closely associated
a)
Name:
Tim Hall
2.
Reason for the notification
a)
Position/status:
Chief Financial Officer
b)
Initial notification/Amendment:
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name:
LiDCO Group Plc
b)
LEI:
213800PYQTIUV6HIYL36
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument:
Identification code:
Ordinary Shares of 0.5 pence each
GB0030546849
b)
Nature of the transaction:
Grant of Management Share Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
0.50 pence per share
2,000,000
d)
Aggregated information:
· Aggregated volume:
· Price:
Single transaction as in 4 c) above
Price(s)
Volume(s)
0.50 pence per share
2,000,000
e)
Date of the transaction:
15-04-2019
f)
Place of the transaction:
London Stock Exchange, AIM (XLON)
For further information, please contact:
LiDCO Group Plc
www.lidco.com
Matt Sassone (CEO)
Tim Hall (CFO)
Tel: +44 (0)20 7749 1500
finnCap
Tel: +44 (0)20 7600 1658
Geoff Nash / Hannah Boros (Corporate Finance)
Andrew Burdis (ECM)
Walbrook PR Ltd
Tel: 020 7933 8780 orlidco@walbrookpr.com
Paul McManus (Media Relations)
Mob: 07876 741 001
Lianne Cawthorne (Media Relations)
Mob: 07584 391 303
Attachments
Original document
Permalink
Disclaimer
LIDCO Group plc published this content on 16 April 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 16 April 2019 06:37:05 UTC
Lidco Group Ltd, formerly LiDCO Group Plc, is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment. The Company's products include LiDCOplus, a computer-based platform monitor; LiDCOrapid, a cardiac output monitor; LiDCOview, a graphical display, and LiDCOunity, which is its hemodynamic monitor. Its LiDCOrapid is designed for multi-parameter monitoring of both depth of anesthesia and fluids. Its products are used in the treatment of high-risk patients in both critical care units and in the operating theatre. They monitor the amount of blood flowing around the body helping clinicians and nurses to ensure that organs are kept perfused with oxygenated blood.